ProCE Banner Activity

Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021 – Prof. Stefan Zeuzem

Multimedia
Conference Coverage
Listen to expert insights from Stefan Zeuzem, MD, on updates and new viral hepatitis data from AASLD 2021, including HBV treatment in pregnancy, outcomes following HBV treatment withdrawal, progress toward HBV cure, HCV implementation science and care cascades, characterization of the population with hepatitis delta, and more.

Released: November 30, 2021

Expiration: November 29, 2022

Share

Faculty

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Learning Objectives

Faculty Disclosure

Primary Author

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, Intercept, Janssen, Novo Nordisk, and Sobi and fees for non-CME/CE services from AbbVie, Gilead Sciences, and MSD.